Strongyloides stercoralis is an intestinal parasite that can cause fatal opportunistic infections in immunocompromised patients. Here we report an immunocompromised patient with glioblastoma who developed disseminated strongyloidiasis 6 weeks after completion of standard radiotherapy and concurrent temozolomide chemotherapy. She was effectively treated with albendazole and ivermectin. Strongyloidiasis should be considered in patients being treated for glioma who have lived or traveled to high risk areas and developed gram negative sepsis, along with gastrointestinal or respiratory symptoms, skin rash or SIADH.
|Original language||English (US)|
|Number of pages||5|
|Journal||Journal of neuro-oncology|
|State||Published - Apr 8 2009|
All Science Journal Classification (ASJC) codes
- Clinical Neurology
- Cancer Research